Sort
48,018 grants matching “immunotherapy”
Innate Antiviral Signals for Cancer Immunotherapy
$390,425Matthias Gromeier · Duke University · R01 · FY2024 · NS
Treatment of Primary Amoebic Meningoencephalitis via Modulation of Antibody Effector Functions
$390,425E. Ashley Moseman · Duke University · R01 · FY2024 · NS
Molecular Mechanisms in Gastrointestinal Stromal Tumor
$390,425Ronald P Dematteo · University Of Pennsylvania · R01 · FY2019 · CA
Mechanism and therapeutic potential of microglia regulation in glioblastoma
$390,425Peiwen Chen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · NS
Biased chemokine receptor signaling in cancer progression
$390,393Michael B Dwinell · Medical College Of Wisconsin · R01 · FY2019 · CA
Mapping the Critical Epitopes of Ara h 2 and Ara h 6
$390,389Stephen C. Dreskin · University Of Colorado Denver · R01 · FY2014 · AI
HER3-PHF8 signaling axis in triple-negative breast cancer progression
$390,376Bolin Liu · Lsu Health Sciences Center · R01 · FY2024 · CA
Biomaterial Drones for Image-Guided Drug Delivery during radiotherapy
$390,321Wilfred Ngwa · Johns Hopkins University · R01 · FY2021 · CA
PEPTIDE MEDIATED IMMUNOTHERAPY FOR AUTOIMMUNE DISEASE
$390,270Stanford University · R01 · FY2002 · NS
Intracerebrally delivered EGFRvIII-targeted CARs for brain tumors
$390,265John H Sampson · Duke University · P50 · FY2018 · CA
Accelerated CD8 T cell memory after DC vaccination
$390,260John T. Harty · University Of Iowa · R01 · FY2006 · AI
Advanced Rigidity-based Material for Enhanced Immunotherapy
$390,137Lance C Kam · Columbia Univ New York Morningside · R01 · FY2015 · AI
BET protein antagonist-based targeted therapy of Mantle Cell Lymphoma
$390,134Kapil N. Bhalla · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Project 2: Reversing STING-mediated immunosuppression in LKB1-mutant lung adenocarcinoma
$390,089Haian Fu · Emory University · P01 · FY2023 · CA
Novel Therapeutic Approaches for the Treatment of Neuroblastoma
$390,077Michael A Dyer · St. Jude Children'S Research Hospital · R01 · FY2024 · CA
Epigenetic Reprogramming of T cell Exhaustion To Enhance Tumor Immunotherapy
$390,077Benjamin Alan Youngblood · St. Jude Children'S Research Hospital · R01 · FY2024 · CA
IDENTIFYING NOVEL IMMUNE EVASION TUMOR IMMUNE NETWORKS AS TARGETS FOR CCRCC IMMUNOTHERAPY
$390,033Sinai Health System · · FY2022 · Defense Health Agency
Combining Irreversible Electroporation with Immunotherapy for the Systemic Treatment of Pancreatic Cancer
$390,030Rebekah White · University Of California, San Diego · R01 · FY2025 · CA
Regulation of the STING pathway under sterile conditions
$390,000Sonal Srikanth · University Of California Los Angeles · R01 · FY2023 · AI
Cytokine Gene Expression During In Vivo Immune Response
$390,000William Clark Gause · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2009 · AI
B Cells in Transplantation Tolerance
$390,000Anita S. Chong · University Of Chicago · R01 · FY2010 · AI
Osteomucosal healing and immunity in medication-related osteonecrosis of the jaw
$390,000Reuben Han-Kyu Kim · University Of California Los Angeles · R56 · FY2023 · DE
Understanding the Mechanism of Mucosal Immunotherapy
$390,000Arvil Wesley Burks · Duke University · R01 · FY2007 · AI
Exploiting public genomic and transcriptomic data to uncover cancer-RNA editing relationships
$390,000Xinshu Grace Xiao · University Of California Los Angeles · R01 · FY2025 · CA
Leveraging single-cell co-culture and gene expression profiling to identify tumor antigen-specific T cells in oral cancer
$390,000Joseph Zenga · Medical College Of Wisconsin · R01 · FY2025 · DE